Atwood & Palmer Inc Regeneron Pharmaceuticals, Inc. Transaction History

Atwood & Palmer Inc

  • $1.51 Billion
  • Q3 2025

A detailed history of Atwood & Palmer Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Atwood & Palmer Inc holds 41,431 shares of REGN stock, worth $28.7 Million. This represents 1.55% of its overall portfolio holdings.

Number of Shares
41,431
Previous 41,588 0.38%
Holding current value
$28.7 Million
Previous $21.8 Million 6.7%
% of portfolio
1.55%
Previous 1.55%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 15, 2025
SELL
$534.91 - $598.71 $83,980 - $93,997
-157 Reduced 0.38%
41,431 $23.3 Million
Q2 2025

Jul 08, 2025
SELL
$483.07 - $625.6 $186,465 - $241,481
-386 Reduced 0.92%
41,588 $21.8 Million
Q1 2025

Apr 15, 2025
SELL
$634.14 - $744.83 $1.08 Million - $1.27 Million
-1,709 Reduced 3.91%
41,974 $26.6 Million
Q4 2024

Jan 16, 2025
SELL
$701.85 - $1046.91 $82,116 - $122,488
-117 Reduced 0.27%
43,683 $31.1 Million
Q3 2024

Oct 07, 2024
SELL
$1024.09 - $1201.76 $60,421 - $70,903
-59 Reduced 0.13%
43,800 $46 Million
Q2 2024

Jul 10, 2024
SELL
$883.2 - $1071.19 $69,772 - $84,624
-79 Reduced 0.18%
43,859 $46.1 Million
Q1 2024

Apr 10, 2024
SELL
$902.69 - $993.35 $483,841 - $532,435
-536 Reduced 1.21%
43,938 $42.3 Million
Q4 2023

Jan 12, 2024
SELL
$775.18 - $881.7 $659,678 - $750,326
-851 Reduced 1.88%
44,474 $39.1 Million
Q3 2023

Oct 20, 2023
SELL
$692.45 - $844.37 $103,867 - $126,655
-150 Reduced 0.33%
45,325 $37.3 Million
Q2 2023

Jul 18, 2023
BUY
$700.03 - $830.35 $2.38 Million - $2.82 Million
3,393 Added 8.06%
45,475 $32.7 Million
Q1 2023

Apr 21, 2023
BUY
$680.49 - $826.97 $61,244 - $74,427
90 Added 0.21%
42,082 $34.6 Million
Q4 2022

Jan 31, 2023
BUY
$705.89 - $766.39 $57,177 - $62,077
81 Added 0.19%
41,992 $30.3 Million
Q3 2022

Oct 12, 2022
BUY
$573.97 - $724.32 $246,233 - $310,733
429 Added 1.03%
41,911 $28.9 Million
Q2 2022

Jul 21, 2022
BUY
$548.35 - $738.84 $236,338 - $318,440
431 Added 1.05%
41,482 $24.5 Million
Q1 2022

Apr 29, 2022
BUY
$595.12 - $698.43 $175,560 - $206,036
295 Added 0.72%
41,051 $28.7 Million
Q4 2021

Jan 24, 2022
BUY
$543.48 - $670.97 $6.77 Million - $8.36 Million
12,454 Added 44.0%
40,756 $25.7 Million
Q3 2021

Oct 19, 2021
BUY
$574.03 - $680.96 $72,327 - $85,800
126 Added 0.45%
28,302 $17.1 Million
Q2 2021

Jul 26, 2021
BUY
$472.8 - $558.54 $13.3 Million - $15.7 Million
28,026 Added 18684.0%
28,176 $15.7 Million
Q1 2021

Apr 26, 2021
BUY
$446.73 - $548.2 $22,336 - $27,410
50 Added 50.0%
150 $71,000
Q4 2020

Feb 04, 2021
BUY
$478.3 - $607.98 $11,957 - $15,199
25 Added 33.33%
100 $48,000
Q3 2020

Oct 28, 2020
BUY
$544.75 - $658.21 $40,856 - $49,365
75 New
75 $42,000

Others Institutions Holding REGN

# of Institutions
1,466
Shares Held
86.5M
Call Options Held
2.38M
Put Options Held
1.61M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Atwood & Palmer Inc Portfolio

Follow Atwood & Palmer Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atwood & Palmer Inc, based on Form 13F filings with the SEC.

News

Stay updated on Atwood & Palmer Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email